GSK reopens OTC plant after gas leak causes a stink

- Last updated on GMT

Related tags: Glaxosmithkline

Methane from sewer at GSK's Aiken site shut operations last week
Methane from sewer at GSK's Aiken site shut operations last week
Drug giant GlaxoSmithKline says operations have restarted at an OTC plant forced to close last week following a methane leak.

The Aiken, South Carolina facility manufactures a number of over-the-counter drugs including Panadol, Alli, Ecotrin, Beano, Sominex, Phazyme and Nicorette Lozenges, but operations came to a halt last Tuesday when elevated methane levels were detected in the sewer system at the site.

200 workers were told not to return until the problem had been addressed but, according to a statement from GSK sent to in-Pharmatechnologist.com, operations resumed last Wednesday at 9p.m.

“The sewer system has been addressed, and methane readings are down to a safe level,”​ the company said.

“As an additional safety step, the site increased ventilation in the impacted area, and a crew is monitoring the sewer system by taking methane readings every 30 minutes.”

No products were impacted during the closure and employees were kept up to date on the situation, GSKtold us.

Related topics: Markets & Regulations, QA/QC

Related news

Show more

Follow us

Products

View more

Webinars